Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Melissa Andres, BSN, RN, OCN

Advertisement

Articles by Melissa Andres, BSN, RN, OCN

Melissa Andres on the Role of the Nurse Navigator

ByMelissa Andres, BSN, RN, OCN
January 3rd 2017

Melissa Andres explains the role of the nurse navigator for patients with cancer.

Melissa Andres Explains the Patient Navigator's Role in Eliminating Barriers

ByMelissa Andres, BSN, RN, OCN
October 20th 2016
Advertisement

Latest Updated Articles

  • Melissa Andres Explains the Patient Navigator's Role in Eliminating Barriers
    Melissa Andres Explains the Patient Navigator's Role in Eliminating Barriers

    October 20th 2016

  • Melissa Andres on the Role of the Nurse Navigator
    Melissa Andres on the Role of the Nurse Navigator

    January 3rd 2017



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Iberdomide for Relapsed or Refractory Multiple Myeloma

2

Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit

3

Ovarian Reserve Markers Predict Chemotherapy Benefit in Breast Cancer

4

Myeloma Care: Quad Therapies, Bispecifics, and the Role of Oncology Nurses

5

Advancing Frontline Treatment in Metastatic Triple-Negative Breast Cancer with ADCs

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us